series-a
Stage
2015
Founded
1
Investors
About
A clinical-stage biotechnology company pioneering a new class of brain metabolism-based therapeutics for neurological and metabolic diseases.
Explore Cerecin's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.